6 results on '"PAPP-A"'
Search Results
2. The first trimester aneuploidy biochemical markers in IVF/ICSI patients have no additional benefit compared to spontaneous conceptions in the prediction of pregnancy complications.
- Author
-
Szymusik, Iwona, Kosinski, Przemyslaw, Kosinska-Kaczynska, Katarzyna, Warzecha, Damian, Karwacka, Anetta, Kaczynski, Bartosz, and Wielgos, Miroslaw
- Subjects
- *
ANEUPLOIDY , *BIOMARKERS , *BIRTH size , *BLOOD proteins , *GESTATIONAL diabetes , *FERTILIZATION in vitro , *GESTATIONAL age , *HYPERTENSION in pregnancy , *PREMATURE infants , *LONGITUDINAL method , *EVALUATION of medical care , *SCIENTIFIC observation , *PREECLAMPSIA , *PREGNANCY complications , *FIRST trimester of pregnancy , *PREGNANCY proteins , *PRENATAL diagnosis , *PREGNANCY - Abstract
Objectives: The aim of this study was to determine if the levels of biochemical aneuploidy markers in in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) pregnancies differ from those in spontaneous pregnancies and to verify if biochemical markers could predict pregnancy outcome in IVF/ICSI gestations. Methods: This was a prospective observational study performed in a group of 551 patients who underwent a combined first trimester prenatal screening (ultrasound scan and serum markers). All patients were divided into two groups according to the mode of conception: IVF/ICSI pregnancies (study group) and spontaneous conceptions (control group). The concentrations of first trimester biochemical markers were presented as multiples of median (MoM) and were compared between the study and control groups. Analysed pregnancy complications included: preterm delivery (PTD), small for gestational age (SGA), gestational hypertension (GH), preeclampsia (PE) and gestational diabetes (GDM). Results: The analysis was performed on 183 IVF/ICSI and 368 spontaneously conceived gestations, with complete data regarding obstetric outcome. There were no significant differences in the concentrations of biochemical markers between the analysed groups. Pregnancy-associated plasma protein-A (PAPP-A) levels were lower in hypertensive than in normotensive patients, although the difference was not significant. Twenty-three patients had GDM (12.5%), 16 had GH or PE (8.7%), SGA was diagnosed in 18 (9.8%) and 25 delivered preterm (13.6%). Conclusions: The trend for lower PAPP-A MoM was visible in all affected patients, although the results did not reach statistical significance. The first trimester biochemical markers in assisted reproduction technique (ART) pregnancies do not seem to have additional effect on predicting the risk of pregnancy complications. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
3. Fetal volume at 11-14 gestational weeks: reference ranges and association with first trimester biochemical and biophysical markers.
- Author
-
Papastefanou, Ioannis, Kappou, Dimitra, Souka, Athena P., Chrelias, Charalambos, Siristatidis, Charalambos, Pilalis, Athanasios, and Kassanos, Demetrios
- Subjects
- *
ULTRASONIC imaging , *STATISTICAL correlation , *FETUS , *FETAL ultrasonic imaging , *LONGITUDINAL method , *SCIENTIFIC observation , *FIRST trimester of pregnancy , *REFERENCE values , *REGRESSION analysis , *WEIGHTS & measures , *DESCRIPTIVE statistics - Abstract
Aims: To establish reference ranges for fetal volume (FV) measured by three-dimensional ultrasound (3D-US) at 11-14 weeks of gestation and to examine the possible association of FV with maternal/pregnancy characteristics and biochemical parameters. Methods: Prospective observational study on 240 fetuses at 11-14 weeks. FV was measured by 3D-US using Virtual Organ Computer-Aided Analysis. Pearson correlation coefficient (cc) and regression analysis were used. Results: FV increased exponentially with crown rump length and was unrelated to maternal weight (cc=-0.137, P=0.071), age (cc=0.009, P=0.899), parity (0.76), smoking status ( t-test, P=0.149) and mode of conception ( t-test, P=0.8). Z-scores (z) of FV was not associated with z-mean uterine artery pulsatility index (cc=-0.026, P=0.733), log10 multiples of the median (MoM) free beta human chorionic gonadotrophin (cc=0.002, P=0.982), delta value (d) of nuchal translucency (cc=0.072, P=0.331) and d-fetal heart rate (cc=0.009, P=0.902), z-FV was significantly positively correlated with log10 MoM pregnancy associated plasma protein-A (PAPP-A; regression coefficient=1.420976, R2=0.0957, P<0.0001). Conclusions: FV is strongly related to PAPP-A even after adjustment for crown rump length with a mechanism unrelated to placental perfusion. FV is independent of the vast majority of first trimester parameters; hence, it is a promising marker of early fetal growth. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
4. Chromosomal mosaicisms in prenatal diagnosis: correlation with first trimester screening and clinical outcome.
- Author
-
Eckmann-Scholz, Christel, Mallek, Julia, Von Kaisenberg, Constantin S., Arnold, Norbert K., Jonat, Walter, Reiner, Siebert, Caliebe, Almuth, and Heidemann, Simone
- Subjects
- *
MOSAICISM , *MEDICAL screening , *DIAGNOSTIC services , *PRENATAL diagnosis , *CHORIONIC gonadotropins , *BLOOD proteins , *PREGNANCY , *AMNIOCENTESIS , *CHROMOSOME abnormalities , *FETAL ultrasonic imaging , *RETROSPECTIVE studies , *PREVENTION - Abstract
Objective: To investigate the outcome of pregnancy after detection of chromosomal mosaicism and to determine the correlation between human chorionic gonadotropin (free β-HCG) and pregnancy-associated plasma protein-A (PAPP-A) levels from first-trimester-screening with pregnancy outcome. Methods: In a single-center, retrospective survey of the results of prenatal diagnostics performed between January 2000 and March 2011, we identified a total of 40 pregnancies with chromosomal mosaicism. Clinical characteristics and results of first-trimester screening, as well as the outcome of these cases, are described. Results: Out of 40 cases, 21 were defined as confined placental mosaicism, 10 classified as true mosaicism and nine were not classifiable cases. Nuchal translucency (NT) was ≥2.5 mm in 8/30 cases with respective measurements. PAPP-A levels were ≤0.4 MoM in 9/26 cases, with respective measurements, two of them being newborns with growth restriction. Remarkably, in pregnancies of all four children born with severe growth retardation, <3rd percentile PAPP-A levels were below 0.52 MoM. Conclusions: Our observations show mosaic pregnancy outcomes to be very heterogeneous. Nevertheless, a combination of low PAPP-A and interpretation of chromosomal mosaicism might identify pregnancies at particular risk for fetal growth restriction. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
5. Estimating the effect of gestational age on test performance of combined first-trimester screening for Down syndrome: a preliminary study.
- Author
-
van Heesch, Peter N., Struijk, Pieter C., Laudy, Jaqueline A. M., Steegers, Eric A. P., and Wildschut, Hajo I. J.
- Subjects
- *
GESTATIONAL age , *DOWN syndrome , *DURATION of pregnancy , *GLYCOPROTEIN hormones , *CHORIONIC gonadotropins - Abstract
Objective: To establish how different methods of estimating gestational age (GA) affect reliability of first-trimester screening for Down syndrome. Methods: Retrospective single-center study of 100 women with a viable singleton pregnancy, who had first-trimester screening. We calculated multiples of the median (MoM) for maternal-serum free beta human chorionic gonadotropin (free β-hCG) and pregnancy associated plasma protein-A (PAPP-A), derived from either last menstrual period (LMP) or ultrasound-dating scans. Results: In women with a regular cycle, LMP-derived estimates of GA were two days longer (range –11 to 18), than crown-rump length (CRL)-derived estimates of GA whereas this discrepancy was more pronounced in women who reported to have an irregular cycle, i.e., six days (range –7 to 32). Except for PAPP-A in the regular-cycle group, all differences were significant. Consequently, risk estimates are affected by the mode of estimating GA. In fact, LMP-based estimates revealed ten “screen-positive” cases compared to five “screen-positive” cases where GA was derived from dating-scans. Conclusion: Provided fixed values for nuchal translucency are applied, dating-scans reduce the number of screen-positive findings on the basis of biochemical screening. We recommend implementation of guidelines for Down syndrome screening based on CRL-dependent rather than LMP-dependent parameters of GA. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
6. The efficacy of first-trimester PAPP-A and free βhCG levels for predicting adverse pregnancy outcome.
- Author
-
Kavak, Zehra Nese, Basgul, Alin, Elter, Koray, Uygur, Meltem, and Gokaslan, Husnu
- Subjects
- *
FIRST trimester of pregnancy , *FETAL monitoring , *GESTATIONAL age , *DELIVERY (Obstetrics) , *HYPERTENSION in pregnancy , *CLINICAL immunology - Abstract
Objective: To determine whether first-trimester measurements of maternal serum PAPP-A and free βhCG levels were associated with adverse pregnancy outcomes. Study Design: First trimester maternal serum free βhCG and PAPP-A were measured in 490 singleton pregnancies. Pregnancies were followed by the fetal-maternal unit, and predictive efficacy of these markers for small for gestational age (SGA) babies, gestational diabetes mellitus and hypertensive disorders were analyzed by cut-off values determined by using a ROC analysis, and also, by using the fifth percentile as the cut-off value. Results: The sensitivities for PAPP-A in predicting pregnancies with a SGA baby and those complicated by a hypertensive disorder were 49% and 73%, respectively, when optimal cut-off values were used. Specificities were 76% and 65%, respectively. Serum free βhCG had no predictive value for individual pregnancy outcomes. Conclusion: Efficacy of first trimester maternal serum markers in predicting adverse pregnancy outcome is low. Even after optimization of cut-off values, these markers do not appear to be clinically acceptable as an effective tool for screening for adverse pregnancy outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.